cl make offici announc noel
wallac ceo
cl announc close noel wallac elect presid ceo
effect april ascens began earnest mr wallac
name global innov growth hill promot presid
past juli wallac colgat sinc well known street
recent present compani growth strategi earn call
implic ceo transit
ceo transit typic rais question could chang portfolio
colgat role develop plan expect major chang
said expect investor focu sever key area invest level one
key debat see center around whether cl spend suffici
support innov new channel like e-commerc also battl competit
particularli key emerg market forecast increas ad spend
 cl well-deserv reput cautiou deal
recent growth challeng chang landscap across consum stapl
desir increas invest commun earn call see
potenti wallac show greater appetit inorgan growth cl
execut acquisit sinc hill investor long
question strateg rational cl pet food busi run separ
oral portfolio howev hill take share
rate cl buy rais po
big step-up spend signific product relaunch price year
cl abil turn around troubl busi hill likelihood re-
acceler seem improv rais po reflect
ep vs previous stapl multipl move higher would put
cl valuat higher end peer group histor case
see potenti invest reinvigor cl improv growth
net dbt
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
person household fabric pet nutrit
brand includ ajax fab softsoap palmol
mennen speed stick hill pet nutrit
colgate-palmol product market
cl heavi exposur develop market
command market share oral care posit
compani well outpac peer earn
cash flow result see cl one
attract long-term growth stori larg
impact result recent see subsid
expect growth acceler next
price object base forward price-to-earnings ep estim
premium large-cap stapl closer compani histor averag rel
market time cl gener best-in-class organ sale growth
demonstr abil manag difficult macro-economic/curr
environ recent result challeng organ sale improv
price ramp longer term see advantag countri categori exposur
risk downsid increas price competit stronger us macro
volatil particularli emerg market
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
qualiti earn
